Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 2/20 | 0.50 |
| ▸ | THRB | P10828 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 2/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
| ▸ | BCL9 | O00512 | 1/20 | 0.40 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15713061 | 0.81 | THRB (0.45) | MGLLTHRBTP53BCL9CTNNB1 | |
| SCHEMBL4434133 | 0.80 | MGLL (0.44) | MGLLTHRBTP53FAAHTRPV1 | |
| SCHEMBL4433141 | 0.78 | MGLL (0.52) | MGLLTHRBTP53FAAHTRPV1 | |
| SCHEMBL25381206 | 0.78 | MGLL (0.56) | MGLLTHRBTP53FAAHTRPV1 | |
| SCHEMBL3111043 | 0.77 | ALDH1A1 (0.40) | ALDH1A1KMT2A | |
| SCHEMBL12160221 | 0.75 | FAAH (0.46) | FAAHTRPV1ALDH1A1KDM4ERAB9A | |
| SCHEMBL31414907 | 0.75 | MGLL (0.56) | MGLLTHRBFAAHTRPV1BCL9 | |
| SCHEMBL31414904 | 0.75 | MGLL (0.53) | MGLLTHRBTP53FAAHTRPV1 | |
| SCHEMBL22370754 | 0.74 | MGLL (0.47) | MGLLTHRBTP53FAAHTRPV1 | |
| SCHEMBL18703462 | 0.74 | MGLL (0.78) | MGLLFAAHTRPV1BCL9CTNNB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100145057-A1 | NOVEL PRODRUGS | SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) | 2010-06-10 | — | — | US | disclosed |
| US-20100145057-A1 | NOVEL PRODRUGS | SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) | 2010-06-10 | — | — | US | disclosed |
| US-20100145057-A1 | NOVEL PRODRUGS | SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) | 2010-06-10 | — | — | US | disclosed |
| EP-2118052-A2 | NOVEL PRODRUGS | Sun Pharma Advanced Research Company Ltd (IN) | 2009-11-18 | — | — | EP | disclosed |
| WO-2008111096-A2 | NOVEL PRODRUGS | SUN PHARMA ADVANCED RESEARCH COMPANY LTD (IN) | 2008-09-18 | — | — | WO | disclosed |
| WO-2008111096-A2 | NOVEL PRODRUGS | SUN PHARMA ADVANCED RESEARCH COMPANY LTD (IN) | 2008-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100145057-A1 | NOVEL PRODRUGS | UGT2B7, UGT1A1, UGT1A6 | MGLL 1615/4885THRB 1673/4885TP53 2178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.